Long-Term Safety and Efficacy of Twice-Daily Topical Clascoterone Cream 1% in Patients Greater Than or Equal to 12 Years of Age With Acne Vulgaris

August 2023 | Volume 22 | Issue 8 | 810 | Copyright © August 2023

Published online July 31, 2023

Lawrence F. Eichenfield MD^a, Adelaide A. Hebert MD^b, Linda Stein Gold MD^c, Martina Cartwright PhD^d, Luigi Moro PhD^e, Jenny Han MS^f, Nicholas Squittieri MD^g, Alessandro Mazzetti MD^e

^aUniversity of California San Diego School of Medicine, La Jolla, CA; Rady Children’s Hospital San Diego, San Diego, CA
^bUTHealth McGovern Medical School, Houston, TX

^cDepartment of Dermatology, Henry Ford Medical Center, Detroit, MI

^dCassiopea Inc., San Diego, CA

^eCassiopea S.p.A., Lainate, Italy 

^fPharmapace Inc., San Diego, CA

^gSun Pharmaceutical Industries, Inc., Princeton, NJ